A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/66 (2006.01) A61K 31/505 (2006.01) A61K 31/675 (2006.01)
Patent
CA 2600025
This invention provides for a method of synergistically reducing viral load in a patient infected with a virus. The method comprises the oral co- administering an amount of thiophosphonoformic acid and an amount of a nucleoside or nucleotide reverse transcriptase inhibitor in a synergistic combination.
Cette invention concerne une méthode permettant de réduire de façon synergétique une charge virale chez un patient infecté par un virus. La méthode décrite dans cette invention consiste à administrer par voie orale une quantité d'acide thiophosphonoformique et une quantité d'un inhibiteur de nucléoside ou de transcriptase inverse de nucléoside mélangées en une combinaison synergétique.
Ramos Silvestri
Robbins Joan
Waninger Shani
Adventrx Pharmaceuticals Inc.
Ridout & Maybee Llp
LandOfFree
The use of thiophosphonoformic acid and nrtis to treat viral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with The use of thiophosphonoformic acid and nrtis to treat viral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of thiophosphonoformic acid and nrtis to treat viral... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1873338